NASDAQ$BTMD

biote Corp · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Headline financials

Total Revenue

-$63.7K

Previous: $31.5M-100.2%
EPS (adj)

$1.23

Previous: $9.02-86.4%
Adjusted EBITDA

$11.7M

No prior period
Free Cash Flow

$1.17M

No prior period
Net Income

$1.17M

Previous: $8.84M-86.7%
Operating Income

-$1.24M

Previous: $9.39M-113.2%
Gross Profit

-$63.7K

Previous: $20.2M-100.3%
Cash & Equivalents

$67.9K

No prior period
Total Assets

$318M

No prior period
R&D Expense

$0.00

Previous: $0.00

Revenue & EPS history

biote · Revenue · Quarterly

-$63.7K

Q1 2022-100.2%vs Q1 2021
Beat estimate in 5 of 9 quarters(56%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

-2.4%

Avg return

Earnings day

-4.0%

Avg return

5 days after

-3.0%

Avg return

30 days after

55%

11 / 20 earnings

Positive

+16.9%

Q3 2024

Best reaction

-25.1%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.9%-9.6%+4.6%
Q4 2025-10.5%-20.9%-7.6%
Q3 2025-2.4%-11.1%-13.0%
Q1 2025+11.3%+17.1%+14.7%
Q4 2024-25.1%-0.7%-11.0%
Q3 2024+16.9%-6.3%+13.7%
Q2 2024-21.2%-17.8%-10.6%
Q1 2024+0.2%+1.0%+11.1%
Q4 2023+11.9%+27.0%+10.1%
Q3 2023-20.2%-18.4%-0.9%
Q2 2023-14.4%-22.0%-23.7%
Q1 2023-17.2%-14.3%-20.6%
Q4 2022+16.6%+34.9%+33.3%
Q3 2022+2.3%+2.5%+7.2%
Q2 2022+1.1%-4.6%-7.4%
Q1 2022+0.6%-36.9%-64.3%
Q4 2021+0.0%+0.0%+0.6%
Q3 2021-0.1%+0.1%+1.0%
Q2 2021+0.0%-0.5%-0.2%
Q1 2021+0.6%+0.6%+3.0%
Q4 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro